1,5,7-Triazabicyclo[4.4.0]dec-5-ene structure
|
Common Name | 1,5,7-Triazabicyclo[4.4.0]dec-5-ene | ||
---|---|---|---|---|
CAS Number | 5807-14-7 | Molecular Weight | 139.20 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 222.3±23.0 °C at 760 mmHg | |
Molecular Formula | C7H13N3 | Melting Point | 125-130 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 88.3±22.6 °C | |
Symbol |
GHS05 |
Signal Word | Danger |
Use of 1,5,7-Triazabicyclo[4.4.0]dec-5-eneTriazabicyclodecene is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | 1,5,7-Triazabicyclo[4.4.0]dec-5-ene |
---|---|
Synonym | More Synonyms |
Description | Triazabicyclodecene is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 222.3±23.0 °C at 760 mmHg |
Melting Point | 125-130 °C(lit.) |
Molecular Formula | C7H13N3 |
Molecular Weight | 139.20 |
Flash Point | 88.3±22.6 °C |
Exact Mass | 139.110947 |
PSA | 27.63000 |
LogP | -1.08 |
Vapour Pressure | 0.1±0.4 mmHg at 25°C |
Index of Refraction | 1.656 |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C: Corrosive; |
Risk Phrases | R34 |
Safety Phrases | S26-S36/37/39-S45 |
RIDADR | UN 1759 8/PG 2 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 8 |
HS Code | 2933599090 |
~76% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: Shen, Hao; Wang, Yang; Xie, Zuowei Organic Letters, 2011 , vol. 13, # 17 p. 4562 - 4565 |
~57% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: PPG INDUSTRIES OHIO, INC.; ZAWACKY, Steven R.; HICKENBOTH, Charles R.; KARABIN, Richard F.; McCOLLUM, Gregory J.; MORIARITY, Thomas C. Patent: WO2011/112594 A1, 2011 ; Location in patent: Page/Page column 18-19 ; |
~90% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: Usachev, Sergei; Gridnev, Alexei Synthetic Communications, 2011 , vol. 41, # 24 p. 3683 - 3688 |
~% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: US2013/289272 A1, ; Paragraph 0022; 0023 ; |
~% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: US2013/289272 A1, ; Paragraph 0024; 0025; 0026; 0027; 0030; 0031; 0032; 0033 ; |
~33% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: WO2011/112594 A1, ; Page/Page column 18 ; |
~% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: US2009/281313 A1, ; Page/Page column 3 ; |
~% 1,5,7-Triazabic... CAS#:5807-14-7 |
Literature: Synthetic Communications, , vol. 41, # 24 p. 3683 - 3688 |
Precursor 7 | |
---|---|
DownStream 6 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
A block copolymer of zwitterionic polyphosphoester and polylactic acid for drug delivery.
Biomater. Sci. 3 , 1105-13, (2015) Polymeric nanoparticles have been widely used as nano-drug delivery systems in preclinical and clinical trials for cancer therapy, and these systems usually need to be sterically stabilized by poly(et... |
|
Up-regulation of miR-21 and miR-23a Contributes to As2 O3 -induced hERG Channel Deficiency.
Basic Clin Pharmacol Toxicol. 116 , 516-23, (2015) Arsenic trioxide (As2O3) is used to treat acute pro-myelocytic leukaemia. However, the cardiotoxicity of long QT syndrome restricts its clinical application. Previous studies showed that As2O3 can dam... |
|
Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
Med. Oncol. 32(1) , 414, (2014) The mammalian peroxiredoxin 2 (Prdx2) is a member of thiol-dependent antioxidant proteins and plays an important role in the progression of colorectal cancer (CRC). The aim of this study was to confir... |
2H-Pyrimido[1,2-a]pyrimidine, 1,3,4,6,7,8-hexahydro- |
MFCD00043003 |
1,3,4,6,7,8-hexahydropyrimido[1,2-a]pyrimidine |
3,4,6,7,8,9-hexahydro-2h-pyrimido[1,2-a]pyrimidine |
Triazabicyclodecene |
EINECS 227-367-1 |
TBD |
1,5,7-Triazabicyclo[4.4.0]dec-5-ene |
1,3,4,6,7,8-hexahydro-2H-pyrimido(1,2-a)pyrimidine |
1,3,4,6,7,8-Hexahydro-2H-pyrimido[1,2-a]pyrimidine |
1,5,7-triazabicyclo-[4.4.0]dec-5-ene |